The Uromigos World Tour moves to Paris. Dr. Bernard Escudier discusses treatment for tumors that progress after first-line immunotherapy. The role of Tivozanib is a focus for the dialogue.
The Uromigos World Tour moves to Paris. Dr. Bernard Escudier discusses treatment for tumors that progress after first-line immunotherapy. The role of Tivozanib is a focus for the dialogue.